Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Legrand

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Environmental Microbiology|December 29, 2016
Metapopulation theory identifies biogeographical patterns among core and satellite marine bacteria scaling from tens to thousands of kilometersMarkus V Lindh, Johanna Sjöstedt, Börje Ekstam, et al.
Ambio|May 30, 2015
Projected future climate change and Baltic Sea ecosystem managementAgneta Andersson, H E Markus Meier, Matyas Ripszam, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Melanoma burden by melanoma stage: Assessment through a disease transition modelIsabelle Tromme, Catherine Legrand, Brecht Devleesschauwer, et al.
Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.
Lung Cancer (Amsterdam, Netherlands)|July 16, 2005
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)Giorgio V Scagliotti, Egbert Smit, Lionel Bosquee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975Egbert F Smit, Jan P A M van Meerbeeck, Pilar Lianes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)Giuseppe Giaccone, Channa Debruyne, Enriqueta Felip, et al.
Frontiers in Microbiology|May 6, 2016
Spatio-Temporal Interdependence of Bacteria and Phytoplankton during a Baltic Sea Spring BloomCarina Bunse, Mireia Bertos-Fortis, Ingrid Sassenhagen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.
Plos One|October 15, 2014
Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical neviIsabelle Tromme, Brecht Devleesschauwer, Philippe Beutels, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Environmental Microbiology|December 29, 2016
Metapopulation theory identifies biogeographical patterns among core and satellite marine bacteria scaling from tens to thousands of kilometersMarkus V Lindh, Johanna Sjöstedt, Börje Ekstam, et al.
Ambio|May 30, 2015
Projected future climate change and Baltic Sea ecosystem managementAgneta Andersson, H E Markus Meier, Matyas Ripszam, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2015
Melanoma burden by melanoma stage: Assessment through a disease transition modelIsabelle Tromme, Catherine Legrand, Brecht Devleesschauwer, et al.
Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.
Lung Cancer (Amsterdam, Netherlands)|July 16, 2005
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)Giorgio V Scagliotti, Egbert Smit, Lionel Bosquee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975Egbert F Smit, Jan P A M van Meerbeeck, Pilar Lianes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)Giuseppe Giaccone, Channa Debruyne, Enriqueta Felip, et al.
Frontiers in Microbiology|May 6, 2016
Spatio-Temporal Interdependence of Bacteria and Phytoplankton during a Baltic Sea Spring BloomCarina Bunse, Mireia Bertos-Fortis, Ingrid Sassenhagen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.
Plos One|October 15, 2014
Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical neviIsabelle Tromme, Brecht Devleesschauwer, Philippe Beutels, et al.
Pageof 11